Copyright
©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 116-123
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.116
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.116
Table 1 Percentage distribution of demographic and disease characteristics of patients with primary hepatocellular carcinoma at Cho Ray Hospital, Ho Chi Minh City, Vietnam, 2010 to 2016
| Characteristic | 2010 (n = 2793) | 2011 (n = 3111) | 2012 (n = 3349) | 2013 (n = 3471) | 2014 (n = 3494) | 2015 (n = 3804) | 2016 (n = 4069) | Total (n = 24091) | P value |
| Male gender | 82.6 | 82.77 | 82.23 | 80.44 | 81.2 | 81.2 | 82.13 | 81.76 | 0.17 |
| Age (yr) | |||||||||
| ≤ 40 | 10.31 | 8.94 | 9.14 | 8.58 | 7.76 | 7.6 | 7.77 | 8.49 | < 0.0001 |
| 41-50 | 19.3 | 18.58 | 17.44 | 17.26 | 17.32 | 17.43 | 16.76 | 17.64 | |
| 51-60 | 30.68 | 30.57 | 29.23 | 30.83 | 29.28 | 29.86 | 29.29 | 29.92 | |
| 61-70 | 21.48 | 22.6 | 24.37 | 23.22 | 26.24 | 26.63 | 27.89 | 24.86 | |
| > 70 | 18.22 | 19.32 | 19.83 | 20.11 | 19.4 | 18.48 | 18.28 | 19.08 | |
| Advanced disease stage | 40.57 | 43.68 | 40.52 | 37.65 | 40.78 | 40.75 | 41.68 | 40.79 | 0.76 |
| HBsAg and anti-HCV testing available (n)1 | n = 2505 | n = 2405 | n = 2773 | n = 3153 | n = 3225 | n = 3616 | n = 3907 | n = 21584 | < 0.0001 |
| HBV infection | 61.72 | 69.94 | 66.35 | 60.1 | 59.69 | 60.87 | 60.23 | 62.28 | |
| HCV infection | 24.79 | 27.32 | 28.96 | 25.06 | 27.13 | 25.06 | 24.98 | 26 | |
| HBV and HCV coinfection | 2.71 | 2.74 | 2.52 | 3.04 | 2.95 | 2.41 | 2.46 | 2.68 | |
| Non-HBV or HCV liver disease | 10.78 | 0 | 2.16 | 11.8 | 10.23 | 11.67 | 12.34 | 8.97 |
Table 2 Distribution of serum alpha-fetoprotein levels in patients with hepatocellular carcinoma, 2010 to 2016
| AFP level (ng/mL) | 2010 (n = 2793) | 2011 (n = 3111) | 2012 (n = 3349) | 2013 (n = 3471) | 2014 (n = 3494) | 2015 (n = 3804) | 2016 (n = 4069) | Total (n = 24091) |
| < 20 | 23.24 | 22.53 | 21.59 | 26.22 | 22.41 | 22.32 | 23.99 | 23.21 |
| > 20-100 | 15.43 | 14.14 | 15.17 | 13.71 | 15.00 | 14.54 | 14.48 | 14.62 |
| > 100-200 | 6.30 | 5.37 | 5.11 | 5.36 | 6.70 | 6.34 | 6.41 | 5.96 |
| > 200-400 | 5.87 | 5.63 | 5.32 | 5.30 | 5.38 | 5.81 | 5.97 | 5.62 |
| > 400 | 47.65 | 50.50 | 50.82 | 46.99 | 48.20 | 49.50 | 47.53 | 48.72 |
| Not recorded | 1.50 | 1.83 | 2.00 | 2.42 | 2.32 | 1.5 | 1.62 | 1.88 |
- Citation: Nguyen-Dinh SH, Do A, Pham TND, Dao DY, Nguy TN, Chen Jr MS. High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016. World J Hepatol 2018; 10(1): 116-123
- URL: https://www.wjgnet.com/1948-5182/full/v10/i1/116.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i1.116
